| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.091 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |